StockData
Kyntra Bio, Inc. logo

Kyntra Bio, Inc. (KYNB) stock

KYNBNasdaqPharmaceutical PreparationsFiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Nov 16, 2026Score 5/30
$2.04−1.16 (-36.25%)

Close on Nov 17, 2026Market cap $8.26MP/E 0.0Yield –

Kyntra Bio total assets

Total assets on the balance sheet at the end of each period.

Kyntra Bio's total assets was $101.08M at Jun 30, 2026. For fiscal 2025 it was $119.59M, down 44.3% from the year before. Over ten years it grew -12.8% a year on average. The highest annual figure on record is $898.65M in fiscal 2017.

Annual total assets

PeriodPeriod endValueChange
FY2025Dec 31, 2025$119.59M-44.3%
FY2024Dec 31, 2024$214.53M-49.3%
FY2023Dec 31, 2023$423.53M-30.6%
FY2022Dec 31, 2022$610.09M-21.2%
FY2021Dec 31, 2021$773.82M-6.4%
FY2020Dec 31, 2020$826.84M-3.6%
FY2019Dec 31, 2019$857.40M-2.6%
FY2018Dec 31, 2018$880.60M-2.0%
FY2017Dec 31, 2017$898.65M+91.4%
FY2016Dec 31, 2016$469.55M-0.2%
FY2015Dec 31, 2015$470.57M-2.7%
FY2014Dec 31, 2014$483.53M–

Quarterly total assets

Change is against the same quarter a year earlier.

PeriodPeriod endValueChange
Q2 FY2026Jun 30, 2026$101.08M-43.2%
Q1 FY2026Mar 31, 2026$109.63M-33.6%
Q4 FY2025Dec 31, 2025$119.59M-44.3%
Q3 FY2025Sep 30, 2025$137.01M-48.2%
Q2 FY2025Jun 30, 2025$178.06M-39.3%
Q1 FY2025Mar 31, 2025$165.21M-54.8%
Q4 FY2024Dec 31, 2024$214.53M-49.3%
Q3 FY2024Sep 30, 2024$264.42M-42.6%
Q2 FY2024Jun 30, 2024$293.20M-43.1%
Q1 FY2024Mar 31, 2024$365.87M-32.1%
Q4 FY2023Dec 31, 2023$423.53M-30.6%
Q3 FY2023Sep 30, 2023$460.43M-24.4%
Q2 FY2023Jun 30, 2023$515.13M-25.0%
Q1 FY2023Mar 31, 2023$538.54M-27.8%
Q4 FY2022Dec 31, 2022$610.09M-21.2%
Q3 FY2022Sep 30, 2022$608.84M-28.4%
Q2 FY2022Jun 30, 2022$686.79M-15.1%
Q1 FY2022Mar 31, 2022$745.93M-5.3%
Q4 FY2021Dec 31, 2021$773.82M-6.4%
Q3 FY2021Sep 30, 2021$850.51M+4.7%
Q2 FY2021Jun 30, 2021$808.62M+0.1%
Q1 FY2021Mar 31, 2021$787.30M-4.5%
Q4 FY2020Dec 31, 2020$826.84M-3.6%
Q3 FY2020Sep 30, 2020$812.02M-9.2%
Q2 FY2020Jun 30, 2020$807.68M-11.7%
Q1 FY2020Mar 31, 2020$824.38M+1.5%
Q4 FY2019Dec 31, 2019$857.40M-2.6%
Q3 FY2019Sep 30, 2019$893.96M+4.5%
Q2 FY2019Jun 30, 2019$915.07M+5.2%
Q1 FY2019Mar 31, 2019$812.40M-6.4%
Q4 FY2018Dec 31, 2018$880.60M-2.0%
Q3 FY2018Sep 30, 2018$855.64M-4.4%
Q2 FY2018Jun 30, 2018$869.92M+60.3%
Q1 FY2018Mar 31, 2018$867.61M+96.4%
Q4 FY2017Dec 31, 2017$898.65M+91.4%
Q3 FY2017Sep 30, 2017$894.89M+84.1%
Q2 FY2017Jun 30, 2017$542.64M–
Q1 FY2017Mar 31, 2017$441.76M–
Q4 FY2016Dec 31, 2016$469.55M–
Q3 FY2016Sep 30, 2016$486.21M–

More Kyntra Bio figures

See a number that looks wrong?